rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
1998-11-24
|
pubmed:abstractText |
Advanced HIV disease is associated with a high prevalence of cervical squamous intra-epithelial lesions (SIL) and of infection with oncogenic human papillomavirus (HPV) genotypes. Triple-combination antiretroviral therapy results in decreased plasma HIV viral load, increased CD4 cell counts and partial restoration of immune functions in patients with severe HIV disease. This study investigated the outcome of SIL in HIV-seropositive women undergoing triple combination antiretroviral treatment.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1459-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9727566-Adult,
pubmed-meshheading:9727566-Anti-HIV Agents,
pubmed-meshheading:9727566-Blotting, Southern,
pubmed-meshheading:9727566-CD4 Lymphocyte Count,
pubmed-meshheading:9727566-Carcinoma, Squamous Cell,
pubmed-meshheading:9727566-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:9727566-DNA, Viral,
pubmed-meshheading:9727566-Female,
pubmed-meshheading:9727566-HIV,
pubmed-meshheading:9727566-HIV Seropositivity,
pubmed-meshheading:9727566-Humans,
pubmed-meshheading:9727566-Middle Aged,
pubmed-meshheading:9727566-Papillomaviridae,
pubmed-meshheading:9727566-Papillomavirus Infections,
pubmed-meshheading:9727566-Polymerase Chain Reaction,
pubmed-meshheading:9727566-Prospective Studies,
pubmed-meshheading:9727566-RNA, Viral,
pubmed-meshheading:9727566-Treatment Outcome,
pubmed-meshheading:9727566-Uterine Cervical Neoplasms,
pubmed-meshheading:9727566-Vaginal Smears,
pubmed-meshheading:9727566-Viral Load
|
pubmed:year |
1998
|
pubmed:articleTitle |
Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
|
pubmed:affiliation |
INSERM U 430 and Université Pierre et Marie Curie, Hôpital Broussais, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|